News & Analysis as of

Health Elections & Politics

Read need-to-know updates, commentary, and analysis on Health issues written by leading professionals.
Hogan Lovells

Fourth Circuit Denies Rehearing in Case With Major Implications for Article III Standing and Trial Court’s Role as Gatekeeper for...

Hogan Lovells on

Last week, the Fourth Circuit denied defendants' petition for rehearing in Sommerville v. Union Carbide, a proposed class action for medical monitoring for alleged exposure to emissions of ethylene oxide (EtO). The denial of...more

McDermott Will & Schulte

This Week in 340B: October 28 – November 3, 2025

McDermott Will & Schulte on

Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more

Holland & Knight LLP

CMS Releases CY 2026 Medicare Physician Fee Schedule Final Rule

Holland & Knight LLP on

The Centers for Medicare & Medicaid Services (CMS) on Oct. 31, 2025, released the calendar year (CY) 2026 Medicare Physician Fee Schedule (PFS) Final Rule, which includes policies related to Medicare physician payment and the...more

Perkins Coie

2025 Illinois Labor and Employment Legislative Roundup

Perkins Coie on

Key Takeaways - In 2025, Illinois boosted paid breaks for nursing mothers, NICU leave, and organ donation rights for part-time employees. Significant amendments to the Workplace Transparency Act will require new...more

Hinshaw & Culbertson - Health Care

Florida Mandates Timely Refunds of Patient Overpayments - What Healthcare Providers Need to Know

Effective January 1, 2026, new Florida legislation imposes strict requirements on healthcare facility licensees and practitioners to refund patient overpayments within a specified timeframe. The law introduces clear...more

Troutman Pepper Locke

FDA Takes Cigarette Graphic Health Warnings Fight to Eleventh Circuit

Troutman Pepper Locke on

On October 27, FDA appealed a decision of the U.S. District Court for the Southern District of Georgia that vacated the agency’s 2020 rule requiring graphic health warnings on cigarette packaging and advertisements. This...more

Stark & Stark

New Insights into Mild TBI: Distinct Brain Injury Patterns Found Even in Patients with Minimal Symptoms

Stark & Stark on

A groundbreaking study published in The American Journal of Neuroradiology (AJNR, November 2025) challenges long-held assumptions about mild traumatic brain injury (mTBI). ...more

Stevens & Lee

Innovation and Privacy Protection: Managing Third-Party Risks in Data-Driven Health Care

Stevens & Lee on

Health care organizations increasingly rely on third-party digital solutions such as tracking pixels, analytics platforms and cloud-based services to enhance patient engagement, streamline operation, and expand telehealth...more

Orrick, Herrington & Sutcliffe LLP

FDA’s Digital Health Advisory Committee Considers Generative AI Therapy Chatbots for Depression

The U.S. Food and Drug Administration’s (FDA) Digital Health Advisory Committee (DHAC) held a public meeting on “Generative Artificial Intelligence-Enabled Digital Mental Health Medical Devices,” with a particular focus on a...more

Health Care Compliance Association (HCCA)

[Event] Regional Healthcare Compliance Conference - December 5th, Houston, TX

Benefit from compliance education and networking in your area! HCCA’s Regional Healthcare Compliance Conferences offer convenient, local compliance education in a variety of locations across the country, and feature...more

ArentFox Schiff

Top Four FDA Compliance Issues for Hospitals and Health Systems: What They Are, Why They Matter, and What To Watch

ArentFox Schiff on

An artificial intelligence (AI) triage model piloted in the emergency department can become a deterioration predictor on med-surg floors and then prioritized on a radiology worklist. A lab‑developed sepsis panel built in the...more

Brownstein Hyatt Farber Schreck

Senators Agree on Compromise to End Government Shutdown

On Nov. 10, the Senate voted 60-40 to pass an amended version of H.R.5371 that replaces the House-passed continuing resolution with new language to re-open the government. Sens. Dick Durbin (D-IL), Maggie Hassan (D-NH),...more

Akerman LLP

From Biologics to Bandages, Skin Substitutes Are No Longer the Biologics You Think They Are...

Akerman LLP on

CMS has a skin substitute problem.   Skin substitutes are wound coverings that are used for burns, trauma, or chronic conditions like wounds associated with diabetes, leg ulcers, etc. According to the National Institutes...more

Polsinelli

3rd Quarter 2025 Analysis - Polsinelli-TrBK Distress Indices

Polsinelli on

The Polsinelli | TrBK Distress Indices are prepared and published quarterly. The indices are contrarian measures of economic performance, and are intended to reflect the level of economic distress in the U.S. economy by...more

Polsinelli

Don’t Let The Stark Law Catch You Off Guard: Risk Remains Despite the Lull

Polsinelli on

Key Takeaways - CMS and DOJ activity related to the Stark Law has been notably quiet in recent years, with no material rule updates since 2023 and limited enforcement actions. This slowdown has left many providers...more

DLA Piper

Supreme Court to hear First Choice Women's Resource Centers, Inc. v. Platkin

DLA Piper on

On December 2, 2025, the United States Supreme Court will hear oral argument in First Choice Women's Resource Centers, Inc. v. Platkin, a case with significant implications for nonprofit donor privacy, First Amendment rights,...more

Mandelbaum Barrett PC

New Appellate Decision Highlights Importance of Medicaid Clinical Eligibility

Mandelbaum Barrett PC on

When most people think about Medicaid, they focus on the financial component — income and asset limits that determine eligibility. For some Medicaid programs, however, the focus needs to be on both financial and clinical...more

McDermott+

Healthcare Preview for the Week of: November 10, 2025

McDermott+ on

On November 9, 2025, the Senate voted to proceed to consideration of a continuing resolution (CR) through January 30, 2026, that includes three full-year appropriations bills for fiscal year (FY) 2026 and additional...more

Wolf, Greenfield & Sacks, P.C.

Navigating Medical Device Regulation and IP Protection in the United States (Part 1 of 2)

In the United States, medical device regulation and intellectual property (IP) protection are governed by complex statutory and regulatory frameworks that are distinct from—but closely related to, and in some cases...more

Maynard Nexsen

Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 257: Biogen’s $2B Investment in North Carolina’s RTP...

Maynard Nexsen on

This episode, hosts Heather and Matthew sit down with Nicole Murphy, Executive Vice President and Head of Pharmaceutical Operations and Technology at Biogen. Nicole shares why Biogen is growing in North Carolina with a $2...more

Venable LLP

Dr. Tidmarsh Resigns as Director of CDER, Leadership Developments in Key FDA Offices, and FDA Announces Reforms to Accelerate...

Venable LLP on

Through our Venable FDA Pulse series, we provide insight into key developments within the Food and Drug Administration (FDA or the Agency), emerging trends, enforcement activity, and other topics impacting stakeholders. ...more

Maynard Nexsen

Alabama Supreme Court Appellate Alert: Decision from November 7, 2025

Maynard Nexsen on

The Alabama Supreme Court issued its weekly release list on Friday, November 7, which included one opinion of interest to the Alabama business community...more

Groom Law Group, Chartered

This Week From the Hill (November 9 – 15, 2025)

Each week while Congress is in session, our Policy team delivers a key update to highlight a topical benefits, health, or retirement news item from the Hill, such as a newly introduced bill, a summary of a committee hearing,...more

Blank Rome LLP

A New Deal For GLP-1s

Blank Rome LLP on

The Trump Administration recently announced a multi-pronged deal with Eli Lilly and Novo Nordisk aimed at lowering the cost of GLP-1 medications used for weight loss and diabetes. While many details remain in flux, the...more

Foley & Lardner LLP

FDA Considers Drug Pricing: Leadership Cites Consumer Cost as a Driver for Changes to Biosimilar Recommendations

Foley & Lardner LLP on

“By streamlining the biosimilar development process and helping advance interchangeability, we can achieve massive cost reductions for advanced treatments for cancer, autoimmune diseases, and rare disorders affecting millions...more

60,220 Results
 / 
View per page
Page: of 2,409

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide